An Act To Reduce Prescription Drug Costs By Requiring Reference-Based Pricing

This bill amends funding provisions for the Maine Prescription Drug Affordability Board by replacing ongoing annual appropriations with a single one-time payment of $1,336,343 for the 2024-25 fiscal year. The legislation directs the State Controller to transfer these funds from the Department of Professional and Financial Regulation's special revenue account to the General Fund's unappropriated surplus. Additionally, the bill allocates specific amounts within this total to cover contracts and hire limited-term staff positions to administer the board's new requirements.